Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,411.26%-745.51K | -7.13%-35.68K | -1,471.30%-327.4K | -1,604.31%-315.03K | -317.92%-67.39K | 81.43%-49.33K | -31.27%-33.31K | 89.60%-20.84K | 137.51%20.94K | -202.13%-16.13K |
| Net income from continuing operations | -340.12%-1.23M | -40.97%-213.41K | -36.31%-101.93K | -725.36%-270.44K | -2,984.89%-646.01K | 81.54%-279.88K | 87.73%-151.39K | 23.83%-74.78K | 59.78%-32.77K | 79.42%-20.94K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Asset impairment expenditure | 907.60%249.05K | ---- | ---- | ---- | ---- | -97.82%24.72K | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | --0 | --147.59K | --549.02K | ---- | ---- | --0 | --0 | --0 |
| Other non cashItems | 749.11%527.93K | 19,958.24%527.93K | -3,931.80%-10K | ---- | ---- | -651.75%-81.33K | 218.88%2.63K | 103.95%261 | -840.94%-36.39K | -2,666.47%-47.84K |
| Change In working capital | -201.23%-290.7K | 7.30%97.36K | -520.01%-225.47K | -313.31%-192.18K | -43.80%29.59K | 180.33%287.16K | 30.57%90.73K | 153.12%53.68K | 276.73%90.09K | -52.17%52.65K |
| -Change in receivables | -3,891.80%-147.5K | 1,541.78%76.56K | -775.71%-73.8K | -766.40%-142.64K | 44.60%-7.62K | -94.17%3.89K | 583.21%4.66K | -228.70%-8.43K | -53.51%21.41K | -190.79%-13.75K |
| -Change in prepaid assets | 574.44%2.75K | 8.48%4.04K | -155.58%-3.33K | 79.54%-3.03K | 12.11%5.06K | 87.36%-579 | -17.51%3.73K | 32.61%5.99K | 10.67%-14.81K | 52.29%4.52K |
| -Change in payables and accrued expense | -151.42%-145.94K | -79.65%16.76K | -364.34%-148.34K | -155.70%-46.51K | -48.06%32.15K | 605.32%283.85K | 24.88%82.34K | 150.05%56.12K | 1,605.34%83.5K | -32.72%61.89K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,411.26%-745.51K | -7.13%-35.68K | -1,519.14%-337.4K | -1,556.56%-305.03K | -317.92%-67.39K | 81.43%-49.33K | -31.25%-33.31K | 89.59%-20.84K | 137.51%20.94K | -202.13%-16.13K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -462.12%-1.81M | 5,148.54%89.75K | -578.78%-1.4M | -992.01%-474.08K | 71.16%-21.12K | -101.28%-321.2K | 114.52%1.71K | 0.33%-206.26K | -280.15%-43.41K | -203.76%-73.23K |
| Net other investing changes | -462.12%-1.81M | 5,148.54%89.75K | -578.78%-1.4M | -992.01%-474.08K | 71.16%-21.12K | -101.28%-321.2K | 114.52%1.71K | 0.33%-206.26K | -5,043.72%-43.41K | -222.05%-73.23K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -462.12%-1.81M | 5,148.54%89.75K | -578.78%-1.4M | -992.01%-474.08K | 71.16%-21.12K | -101.28%-321.2K | 114.52%1.71K | 0.33%-206.26K | -280.15%-43.41K | -203.76%-73.23K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,053.17%2.98M | -373.69%-191.21K | 753.70%1.71M | 11,726.66%1.37M | 93.28K | -53.60%258.11K | 374.15%69.86K | -49.05%200K | -105.93%-11.76K | 0 |
| Net issuance payments of debt | --0 | --0 | ---- | ---- | --0 | 88.21%-2.89K | -1,576.87%-102.89K | 1,729.73%100K | --0 | --0 |
| Net common stock issuance | 1,088.30%3.1M | -286.34%-300K | 1,705.28%1.81M | --1.5M | --100K | -59.85%261K | --161K | -76.74%100K | --0 | --0 |
| Cash dividends paid | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --115.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---240.54K | ---6.71K | ---97.88K | ---129.22K | ---6.72K | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,053.17%2.98M | -373.69%-191.21K | 753.70%1.71M | 11,726.66%1.37M | --93.28K | -53.60%258.11K | 374.15%69.86K | -49.05%200K | -105.93%-11.76K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -68.30%52.17K | 4,320.40%614.7K | 1,472.39%644.78K | -24.36%56.91K | -68.30%52.17K | 390.88%164.59K | -93.88%13.91K | -83.05%41.01K | -32.13%75.23K | 390.88%164.59K |
| Current changes in cash | 478.39%425.39K | -458.40%-137.14K | -10.97%-30.07K | 1,817.51%587.87K | 105.30%4.73K | -185.78%-112.42K | 161.09%38.27K | -84.93%-27.1K | -126.12%-34.23K | -215.57%-89.36K |
| End cash Position | 815.35%477.56K | 815.35%477.56K | 4,320.40%614.7K | 1,472.39%644.78K | -24.36%56.91K | -68.30%52.17K | -68.30%52.17K | -93.88%13.91K | -83.05%41.01K | -32.13%75.23K |
| Free cash from | -1,411.26%-745.51K | -7.13%-35.68K | -1,519.14%-337.4K | -1,556.56%-305.03K | -317.92%-67.39K | 81.43%-49.33K | -31.25%-33.31K | 89.59%-20.84K | 137.51%20.94K | -202.13%-16.13K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.